
Overview
Status
Active
Registry date
2023-10-13
Share capital
1,00 PLN
Registered address
ul. Droga Leśna 59/12, 64-600 Oborniki, Poland
Website
mimobiotech.comWebsite active
Email
Email address current
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Authorized Representatives
Maciej Drożdż — President of the Management Board
Manner of representation
If the management board consists of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Share value | Stake |
|---|---|---|
Maciej Drożdż (53) | $0.27 | 100% |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Read-GeneS.A. | $2,163,474.84 | read-gene.com | ||
| GenxoneS.A. | $665,361.35 | genxone.eu | ||
| Polbiotech Laboratoriumsp. z o.o. | $645,943.81 | polbiotech.pl | ||
| Relvosp. z o.o. | $120,693.26 | relvo.pl | ||
| Microblicsp. z o.o. | $122,383.50 | microblic.pl | ||
| Xenstatssp. z o.o. | $66,774.27 | xenstats.com | ||
| Pominnosp. z o.o. | $65,991.17 | pominno.pl | ||
| 4cell TherapiesS.A. | $9,123.06 | 4celltherapies.com | ||
| Fungotechsp. z o.o. | $187.68 | fungo.tech | ||
| Dystrogen TherapeuticsS.A. | — | dystrogen.com |
FAQ
The main business activity of Mimo Biotech focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on October 13, 2023.
The headquarters is located at: ul. Droga Leśna 59, 64-600 Oborniki.
The management board consists of: Maciej Drożdż (President of the Management Board).
The share capital of the company is PLN 1 (approx. $0).
Last updated: 2026-04-03